Market Research Report
Pharma-Payer Partnerships in Emerging Markets
|Published by||Datamonitor Healthcare||Product code||570533|
|Published||Content info||72 Pages
Delivery time: 1-2 business days
|Pharma-Payer Partnerships in Emerging Markets|
|Published: August 14, 2017||Content info: 72 Pages||
Payer partnerships are becoming widespread as emerging markets become wealthier, but access challenges remain. Partnerships with proven success include "strategic philanthropy," patient access programs, tiered pricing, and service support models. Many of the most successful strategies are hybrids of two or more "pure" partnership archetypes.
This analysis is a survey of recent industry experience with payer partnerships in emerging markets, using case studies and real-world exemplars to illustrate best practice. While there is no "one size fits all" approach to partnering in emerging markets, Datamonitor Healthcare has considered in each case how best to address payer needs that cannot be served by the routine course of business.
This analysis covers self-pay markets, partially reimbursed, and reimbursed emerging markets. Pharmaceutical companies that can overcome payer resistance, and take a proactive approach, can reap significant rewards from innovative partnerships in challenging, high-growth markets.